RE:RE:RE:Patent settlement April 2015, more drugs buys more earnings i actually flagged the one drug risk prior to the pattent challenge and the stock cratered after. I dont see how i was wrong there. It's still a big concern. this company is still a one drug wonder. People are just taking comfort in the fact that it's a cashed up company and they will likely do more deals. I'm a bit surprised they haven't bought something material. Probably their biggest mistake to date was not buying a mature cash flowing drug by now.
Why would i want CPH shares. Charts broken, mature drug now with limited incremental market share opportunitiy. Rather on CRH, GUD, CXR. Whli you lost +50% from the peak, i made money playing those stocks that are up more than CPH.
Good luck. the stock is currently not a buy imo.